Medicine guide

Fentanyl CF 50 µg/uur

As listed in the register: Fentanyl CF 50 µg/uur, pleister voor transdermaal gebruik

50 µg · pleister voor transdermaal gebruik

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Fentanyl
Made by
Centrafarm B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupPain, sleep, mood, epilepsy and the brainN02AB03

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (FENTANYL). It describes the substance, not this exact product.

Fentanyl is an opioid agonist.

Fentanyl interacts predominately with the opioid mu-receptor.

Peak level after20–72 h
How the body breaks it down

Fentanyl is metabolized primarily via human cytochrome P450 3A4 isoenzyme system.

How it leaves the body

Within 72 hours of IV fentanyl administration, approximately 75% of the dose is excreted in urine, mostly as metabolites with less than 10% representing unchanged drug.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-04-07

Safety of the active substance

From the US prescribing label for the same active substance (FENTANYL). It describes the substance, not this exact product.

Serious warning

Life-threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of fentanyl transdermal system, especially during initiation or following a dose increase.

Must not be used by
  • Opioid non-tolerant patients.
  • ( 4 ) Acute or intermittent pain, postoperative pain, mild pain.
  • ( 4 ) Significant respiratory depression.
  • ( 4 ) Acute or severe bronchial asthma in an unmonitored setting or in absence of resuscitative equipment.
Most common side effects

The most common adverse reactions (≥5%) in a double-blind, randomized, placebo-controlled clinical trial in patients with severe pain were nausea, vomiting, somnolence, dizziness, insomnia, constipation, hyperhidrosis, fatigue, feeling cold, and anorexia.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

FranceNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byCentrafarm B.V.
Active substanceFentanyl
Used inPain, sleep, mood, epilepsy and the brain
Strength50 µg
Formpleister voor transdermaal gebruik
ClassificationN02AB03 · Pain, sleep, mood, epilepsy and the brain
Routetransdermaal gebruik
Dispensing (as stated by the register)Uitsluitend recept
Name in the registerFentanyl CF 50 µg/uur, pleister voor transdermaal gebruik
RVG105084

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.